Tag: Biotech

A new decisive phase is coming to South Korea’s biotech sector. Hanmi Pharmaceutical’s Efpeglenatide, the nation’s first homegrown GLP-1 obesity drug, has been granted fast-track review […]

Gosta Labs, a Helsinki-based HealthTech company innovating in the oncology sector, has closed a €7.5 million Seed round to scale its AI operating system for complex […]

Korea’s startup scene is about to pause, reflect, and reimagine its future. In the coming first venture week, the nation’s venture and innovation builders, investors, and […]

Korea’s startup ecosystem has learned to grow fast — perhaps too fast. The past decade’s state-backed acceleration produced record valuations and bold ambitions, but now the […]

Executive reshuffle signals strategic focus on mobile, memory, and next-generation technologies Samsung Electronics has reinstated its dual-CEO management structure as part of its 2026 executive reshuffle, […]

Artios Pharma Limited, a British biopharmaceutical company committed to realising the therapeutic potential of targeting the DNA damage response (DDR) in cancer, today announced the successful […]

Paris-based VC firm Sofinnova Partners has closed its latest flagship fund, Sofinnova Capital XI, at an impressive €650 million – a haul that surpasses its original […]

T-Therapeutics, a British BioTech company developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, today announced the successful expansion of its Series A […]

Stockholm-based BOOST Pharma, a clinical-stage biopharmaceutical company focused on developing novel cell therapies for rare skeletal pediatric diseases, today announced that Sound Bioventures has joined its […]

Source.ag, the Amsterdam-based developer of AI software for Controlled Environment Agriculture (CEA), today announced the successful close of its Series B funding round, raising €15.2 million. […]